In subclinical AF, apixaban reduced stroke or systemic embolism but increased major bleeding vs. aspirin at 3.5 y - KIVIRID

In subclinical AF, apixaban reduced stroke or systemic embolism but increased major bleeding vs. aspirin at 3.5 y

Authors: Ilya Y. Shadrin, L. Kristin Newby

Published: 2024-03-04

DOI: 10.7326/j24-0002

Source: Full article

Abstract

No abstract found.